Recent insider trading activity at two major software companies, SentinelOne and Salesforce, reveals contrasting corporate sentiment as both stocks face significant market pressure in 2026. While SentinelOne insiders sold shares, Salesforce directors bought the dip, painting a nuanced picture of executive confidence.
SentinelOne (S) saw two key insiders sell stock on March 25. Director Ana Pinczuk sold 32,396 units at $13.37 per share, totaling approximately $433,134, reducing her stake by 5.09%. On the same day, Interim CFO Barry Padgett sold 32,221 units at the same price for roughly $430,794. The company clarified that Padgett's sale was mandated to cover tax withholding obligations tied to vesting equity awards. This selling occurred despite SentinelOne reporting a Q4 earnings beat on March 12, with EPS of $0.07 versus a $0.06 estimate and revenue of $271.15 million, up 20.3% year-over-year.
Following the earnings report, multiple analysts trimmed their price targets. Goldman Sachs cut its target from $16.50 to $14.50, UBS moved from $17.00 to $15.00, and Wells Fargo nudged its target from $13.00 to $14.00. Oppenheimer maintained the most bullish view, cutting from $20.00 to $18.00. The stock has fallen 8.2% over the past week and was trading near its 52-week low of $12.23. The consensus analyst rating remains "Moderate Buy" with an average price target of $19.43.
In contrast, Salesforce (CRM) has experienced a severe selloff, dropping more than 30% in 2026 and touching a 52-week low of $174.57. Despite this, two board directors purchased shares in March. Director Laura Alber bought 2,571 shares at just under $195 each on March 19, spending $451,166. Fellow director David Kirk purchased 2,570 shares at $194.62 each on March 18. This buying occurred even as the stock faced pressure from broad software sector selling and fears about AI competition disrupting enterprise software platforms.
Salesforce's fundamentals appear strong; the company reported Q4 EPS of $3.81, beating the $3.05 estimate, with revenue of $11.20 billion. The board also authorized a massive $25 billion share buyback program on March 16. However, these positive developments have not halted the stock's decline, which has fallen another 7% since March 19. Institutional investors increased their positions in Q4 2024, and analyst sentiment remains broadly positive with a consensus price target of $280.21.
